ReviewDrug safety2015

Evaluating AE Reporting of Two Off-Patent Biologics to Inform Future Biosimilar Naming and Reporting Practices.

Stella Stergiopoulos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.